Nika Pharmaceuticals Changes Certifying Accountant
Ticker: NIKA · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1145604
| Field | Detail |
|---|---|
| Company | Nika Pharmaceuticals, Inc (NIKA) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, sec-filing
TL;DR
Nika Pharma switched auditors, effective Sept 23rd.
AI Summary
Nika Pharmaceuticals, Inc. announced on October 1, 2024, a change in its certifying accountant, effective September 23, 2024. The company previously engaged with a different accountant before this change.
Why It Matters
A change in a company's auditor can signal shifts in financial reporting scrutiny or internal control assessments.
Risk Assessment
Risk Level: low — This filing solely reports a change in the company's auditor, which is a routine administrative event.
Key Numbers
- 20241001 — Filing Date (Date the 8-K was filed with the SEC.)
- 20240923 — Effective Date of Change (Date the change in certifying accountant became effective.)
Key Players & Entities
- NIKA PHARMACEUTICALS, INC. (company) — Registrant
- 0001145604 (company) — Central Index Key
- 2269 MERRIMACK VALLEY AVENUE (company) — Business Address
- HENDERSON (company) — City
- NV (company) — State
- 89044 (company) — ZIP Code
- 7023263615 (company) — Business Phone
FAQ
What was the specific reason for changing the certifying accountant?
The filing does not specify the reason for the change in certifying accountant.
Who is the new certifying accountant for Nika Pharmaceuticals, Inc.?
The filing does not disclose the name of the new certifying accountant.
Was there any disagreement with the former certifying accountant?
The filing does not mention any disagreements with the former certifying accountant.
When did the change in certifying accountant become effective?
The change in certifying accountant became effective on September 23, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 2269 Merrimack Valley Avenue, Henderson, NV 89044.
Filing Stats: 286 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2024-10-01 15:39:28
Filing Documents
- form8k.htm (8-K) — 11KB
- 0001826466-24-000128.txt ( ) — 171KB
- nkph-20240923.xsd (EX-101.SCH) — 3KB
- nkph-20240923_lab.xml (EX-101.LAB) — 33KB
- nkph-20240923_pre.xml (EX-101.PRE) — 22KB
- form8k_htm.xml (XML) — 3KB
01 Changes in Registrants Certifying Accountant
Item 4.01 Changes in Registrants Certifying Accountant. On September 23, 2024, Nika Pharmaceuticals, Inc. engaged the firm of OLAYINKA OYEBOLA & CO (Chartered Accountants) to serve as the independent accountant to audit the companys financial statements.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized. NIKA PHARMACEUTICALS, INC. Dated: October 1, 2024 By: /s/ Dimitar Slavchev Savov Dimitar Slavchev Savov Chief Executive Officer, Director